Tivantinib (Compound)

Compound:

tivantinib (43378b72-99cd-4233-92c5-1598ffda0f72)

Synonyms:Tivantinib, 905854-02-6, ARQ-197, ARQ 197, Tivantinib (ARQ 197), (3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione, 905853-99-8, ARQ197, 1000873-98-2, (rel)-Tivantinib

Pubchem:PUBCHEM:11494412

Id:61dd3141-0b73-5e75-aac8-cf69a9994d5a

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Tivantinib's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Tivantinib.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Tivantinib.

Results found

Linked to

	Label	Description
	BRD-K33379087-001-07-5 Substance (Entity type)	A Substance
	Tivantinib in similarity relationship with HMN-214 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tivantinib negatively regulates TOP2A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	N-(4-(3-(2-aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine in similarity relationship with Tivantinib Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tivantinib negatively regulates GLUL Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tivantinib positively regulates PODXL Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tivantinib positively regulates H2AC6 Gene Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tivantinib positively regulates H2BC5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tivantinib bioactivity Eukaryotic translation initiation factor 5B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Tivantinib negatively regulates SPON2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K33379087-001-07-5

Substance (Entity type)

A Substance

Tivantinib in similarity relationship with HMN-214

Knowledge Graph Assertion (Entity type)